Co-creating discovery in basic science: Challenges and opportunities in patient-partnered research for rare liver disease [0.03%]
罕见肝病的患者伙伴研究：基础科学中发现共创造的挑战与机遇
Diana Nakib,Mary Vyas,Rachel Gomel et al.
Diana Nakib et al.
Background: Patient-partnered basic and translational research is the most productive and meaningful approach to developing informed research questions, generating high-quality data, and producing impactful work. While se...
Microbiome alternative treatments for hepatic encephalopathy: Reassessment of the potential use of lactose in lactase non-persistent cirrhosis patients [0.03%]
肝性脑病的微生物组替代疗法：重新评估乳糖在乳糖不耐受肝硬化患者中的潜在应用
Andrew Szilagyi,Polymnia Galiatsatos,Noah Margolese et al.
Andrew Szilagyi et al.
Background: Hepatic encephalopathy is secondary to liver failure and is prevalent in 20%-40% of cirrhosis patients. The cause involves ammonia toxicity, gut-brain interactions, and inflammation usually involving the micro...
Frequency of Helicobacter pylori screening in patients with end-stage liver disease prior to liver transplant [0.03%]
终期肝病患者接受肝移植前Helicobacter pylori筛查的频率
David Mp Di Fonzo,Yu-Chen Luo,Daljeet Chahal et al.
David Mp Di Fonzo et al.
Background: Post-transplant immunosuppression increases malignancy risk. Gastric cancer is one of the most common post-transplant malignancies among high-risk groups including Asian patients. Helicobacter pylori is a know...
Low muscle mass predicts liver-related outcomes in cirrhosis, independent of portal hypertension: A retrospective cohort study [0.03%]
肌张力不令人满意的低肌肉量可独立预测肝硬化患者的肝脏相关结局：一项回顾性队列研究
Ikram Abow-Mohamed,Balqis Alabdulkarim,Xun Zhao et al.
Ikram Abow-Mohamed et al.
Background: Sarcopenia is associated with increased mortality in patients with cirrhosis, but this association remains unclear when adjusted for portal hypertension. We investigated the association of muscle mass and port...
Health care providers' perspectives on barriers and enablers to providing hepatitis C screening and treatment for immigrants in Canada: A theory-informed qualitative study [0.03%]
加拿大为移民提供丙型肝炎筛查和治疗的障碍与促进因素：一项理论为导向的定性研究医务人员视角
Sameh Mortazhejri,Christina Greenaway,Curtis Cooper et al.
Sameh Mortazhejri et al.
Background: Canada has committed to eliminating hepatitis C virus (HCV) by 2030. Despite highly effective treatments, screening and treatment uptake remains suboptimal. Immigrants from HCV-endemic countries account for 35...
Provider attitudes, practices, and barriers in alcohol-associated liver disease care: Findings from the CASL ALD SIG national survey [0.03%]
我国酒精性肝病诊疗现状及挑战——CSPH酒精性肝病协作组全国调查结果
Noreen Singh,Elizabeth Lee,Tasha Kulai et al.
Noreen Singh et al.
Background: Alcohol-associated liver disease (ALD) is a growing health care concern, with alcohol use disorder (AUD) being a contributor to liver-related morbidity and mortality. This study examines the practices, perspec...
Development and evaluation of a hybrid algorithm for identifying hospitalized patients with cirrhosis [0.03%]
肝硬化住院患者的识别：混合算法的开发与评估
Kinjal Patel,Mayur Brahmania,Grace T Wang et al.
Kinjal Patel et al.
Background: Electronic medical record (EMR)-based quality improvement (QI) tools for cirrhosis care require accurate patient identification. Combining administrative and EMR data may enhance cirrhosis identification. This...
Gallbladder neoplasia is associated with a higher incidence of cholangiocarcinoma in patients with primary sclerosing cholangitis [0.03%]
原发性硬化性胆管炎患者中，胆囊肿瘤与较高的胆管癌发生率相关
Mitchell W Clayton,Ross A Dierkhising,Gregory J Gores et al.
Mitchell W Clayton et al.
Background: Patients with primary sclerosing cholangitis (PSC) are at risk for developing gallbladder neoplasia (GBN) and biliary neoplasia, including cholangiocarcinoma (CCA), because of chronic inflammation and an under...
Portosystemic shunt (SPSS) embolization for refractory hepatic encephalopathy [0.03%]
难治性肝性脑病的门体分流(PSPS)栓塞治疗
Nicholas Tjandra,David Mp Di Fonzo,Benjamin Cox et al.
Nicholas Tjandra et al.
Natasha Chandok,Eric M Yoshida
Natasha Chandok